Published in Nat Rev Gastroenterol Hepatol on December 10, 2013
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun (2016) 0.81
Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats. Mol Med Rep (2014) 0.81
PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis. World J Gastroenterol (2015) 0.81
Induction of autophagy and apoptosis by miR-148a through the sonic hedgehog signaling pathway in hepatic stellate cells. Am J Cancer Res (2015) 0.76
Increased Expression of TGF-β1 in Correlation with Liver Fibrosis during Echinococcus granulosus Infection in Mice. Korean J Parasitol (2016) 0.75
Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep (2014) 0.75
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis. Biomed Res Int (2017) 0.75
Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways. Drug Des Devel Ther (2017) 0.75
Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling. Exp Ther Med (2017) 0.75
Stem cells: IL-22 activates ISCs for intestinal regeneration. Nat Rev Gastroenterol Hepatol (2015) 2.02
Autoimmunity: disordered NETs implicated in pathogenesis of MPO-ANCA-associated vasculitis. Nat Rev Rheumatol (2012) 0.92
Colorectal cancer: Fusobacterium nucleatum found in colon cancer tissue--could an infection cause colorectal cancer? Nat Rev Gastroenterol Hepatol (2011) 0.89
Gut microbiota: Colorectal cancer-driven by inflammation and gut bacteria? Nat Rev Gastroenterol Hepatol (2012) 0.83
Hepatitis: NPC1L1 identified as a novel HCV entry factor. Nat Rev Gastroenterol Hepatol (2012) 0.82
IBD. Understanding gut microbiota in new-onset Crohn's disease. Nat Rev Gastroenterol Hepatol (2014) 0.80
Hepatitis: New gene IFNL4 is associated with impaired clearance of HCV. Nat Rev Gastroenterol Hepatol (2013) 0.80
IBS: Linaclotide approved for constipation-predominant IBS. Nat Rev Gastroenterol Hepatol (2012) 0.80
Gut microbiota: married to our gut microbiota. Nat Rev Gastroenterol Hepatol (2012) 0.79
Gut microbiota: Adding weight to the microbiota's role in obesity--exposure to antibiotics early in life can lead to increased adiposity. Nat Rev Gastroenterol Hepatol (2012) 0.79
Endoscopy: Tethered capsule endomicroscopy of the oesophagus--an easy pill to swallow. Nat Rev Gastroenterol Hepatol (2013) 0.79
Colorectal cancer: Liquid biopsy enables real-time monitoring of molecular alterations in CRC. Nat Rev Gastroenterol Hepatol (2015) 0.79
Developmental biology: On the origin of liver regeneration. Nat Rev Gastroenterol Hepatol (2015) 0.78
Pancreatic cancer: Pancreatic cancer exosomes prime the liver for metastasis. Nat Rev Gastroenterol Hepatol (2015) 0.78
NAFLD. Leaky guts: intestinal permeability and NASH. Nat Rev Gastroenterol Hepatol (2015) 0.78
Crystal arthritis: NLRP3 inflammasome mediates crystal-induced joint inflammation and dysfunction. Nat Rev Rheumatol (2011) 0.78
Gut microbiota. Host-microbe interactions and the enteric nervous system: a new connection? Nat Rev Gastroenterol Hepatol (2015) 0.78
IBD. Gut microbiota in IBD goes viral. Nat Rev Gastroenterol Hepatol (2015) 0.78
Therapy: potential of siRNA-based therapies for pancreatic fibrosis. Nat Rev Gastroenterol Hepatol (2012) 0.77
Pancreatitis: T cells have a pivotal role in autoimmune pancreatitis in an experimental mouse model. Nat Rev Gastroenterol Hepatol (2013) 0.77
Therapy. Tissue engineering: harnessing stem cells in cartilage repair. Nat Rev Rheumatol (2012) 0.77
Bone: The immune system takes control of bone homeostasis. Nat Rev Rheumatol (2014) 0.77
Oesophagus: TSLP-basophil axis important in eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2013) 0.77
Imaging: Dual-energy CT useful when assessing tophaceous gout. Nat Rev Rheumatol (2012) 0.76
Infection: Activation of Hedgehog pathway promotes fibrogenesis and vascular remodelling in human schistosomiasis. Nat Rev Gastroenterol Hepatol (2012) 0.76
Malnutrition: New mouse model of EE. Nat Rev Gastroenterol Hepatol (2015) 0.76
Liver: Dietary cholesterol and fat synergistically fuel the development of NASH in experimental models. Nat Rev Gastroenterol Hepatol (2012) 0.76
Gut microbiota: adding weight to the microbiota's role in obesity--exposure to antibiotics early in life can lead to increased adiposity. Nat Rev Endocrinol (2012) 0.76
Pain. Oxytocin analogues have potential in relieving chronic abdominal pain. Nat Rev Gastroenterol Hepatol (2014) 0.76
Inflammation: Maintaining the mucosal barrier in intestinal inflammation. Nat Rev Gastroenterol Hepatol (2015) 0.76
Gut microbiota. Tackling the effects of diet and exercise on the gut microbiota. Nat Rev Gastroenterol Hepatol (2014) 0.76
Experimental arthritis. Tipping the balance: conversion of Foxp3+ T cells to TH17 cells is crucial in autoimmune arthritis. Nat Rev Rheumatol (2014) 0.76
Liver: Sussing out statins in cirrhosis--KLF2 is the key. Nat Rev Gastroenterol Hepatol (2015) 0.76
Liver: Purified A1AT holds promise as therapy for acute liver failure. Nat Rev Gastroenterol Hepatol (2014) 0.76
mtDNA mutations key to prostate cancer development? Nat Rev Urol (2011) 0.76
Gut microbiota: microbial metabolites feed into the gut-brain-gut circuit during host metabolism. Nat Rev Gastroenterol Hepatol (2014) 0.76
Viral hepatitis: Promising phase I trial results for TG4040 vaccine in patients with chronic hepatitis C. Nat Rev Gastroenterol Hepatol (2011) 0.76
Gut microbiota: Obesity-induced microbial metabolite promotes HCC. Nat Rev Gastroenterol Hepatol (2013) 0.76
IBD: Ustekinumab shows promise in the treatment of refractory Crohn's disease. Nat Rev Gastroenterol Hepatol (2012) 0.76
Liver cancer: The promise of new approaches in the management of hepatocellular carcinoma--adding to the toolbox? Nat Rev Gastroenterol Hepatol (2013) 0.76
Microbiota: Tolerating gluten--a role for gut microbiota in celiac disease? Nat Rev Gastroenterol Hepatol (2012) 0.76
Connective tissue diseases: NETing complement in SLE. Nat Rev Rheumatol (2012) 0.75
Endoscopy: New molecular probe for targeted imaging of oesophageal neoplasia in Barrett oesophagus. Nat Rev Gastroenterol Hepatol (2013) 0.75
Microbiota: manipulating the microbiota in obesity. Nat Rev Gastroenterol Hepatol (2012) 0.75
Rheumatoid arthritis: Anti-TNF therapy for RA hinders function and survival of dendritic cells. Nat Rev Rheumatol (2010) 0.75
Migraine: Portable sTMS device relieves the pain of migraine. Nat Rev Neurol (2010) 0.75
IBS: Distinct neuro-immune patterns defined in IBS subtypes. Nat Rev Gastroenterol Hepatol (2012) 0.75
IBD: Fertilizing the gut: host-derived nitrate contributes to Escherichia coli bloom in colitis. Nat Rev Gastroenterol Hepatol (2013) 0.75
Traumatic brain injury: Poor outcome after decompressive craniectomy. Nat Rev Neurol (2011) 0.75
Therapy: Silencing inhibitors of bone formation. Nat Rev Rheumatol (2012) 0.75
Nutrition: Different feeding regimens could affect the development of necrotizing enterocolitis in preterm neonates. Nat Rev Gastroenterol Hepatol (2011) 0.75
Liver: Activation of NF-κB signaling in hepatocytes induces liver fibrosis. Nat Rev Gastroenterol Hepatol (2012) 0.75
Pediatrics: tailoring weight-control programs to teenagers. Nat Rev Gastroenterol Hepatol (2012) 0.75
Prostate cancer: HIFU as primary treatment for prostate cancer: proceed with caution. Nat Rev Urol (2011) 0.75
Hepatitis: Genetic variability in HBV resistance. Nat Rev Gastroenterol Hepatol (2011) 0.75
Therapy: Gastric electrical stimulation relieves nausea and vomiting in the long term. Nat Rev Gastroenterol Hepatol (2012) 0.75
Fibrosis with inflammation is associated with reduced graft function and survival. Nat Rev Nephrol (2011) 0.75
Bladder cancer: Does augmentation cystoplasty increase the risk of bladder cancer? Nat Rev Urol (2010) 0.75
Pancreas: Cortical thickness--a useful indicator in painful chronic pancreatitis? Nat Rev Gastroenterol Hepatol (2012) 0.75
Childhood gastroenteritis--the rise of norovirus. Nat Rev Gastroenterol Hepatol (2013) 0.75
Atrial fibrillation: RE-LY: dabigatran in cardioversion. Nat Rev Cardiol (2011) 0.75
Infection: Understanding how Clostridium difficile infection in health-care settings spread around the world. Nat Rev Gastroenterol Hepatol (2012) 0.75
NAFLD: getting to the heart of NAFLD. Nat Rev Gastroenterol Hepatol (2012) 0.75
Long-term outcomes of living kidney donors are affected by race. Nat Rev Nephrol (2010) 0.75
Infection: Modelling persistent giardiasis and malnutrition. Nat Rev Gastroenterol Hepatol (2013) 0.75
Regenerative medicine: Functional miniature human liver generated from stem cells. Nat Rev Gastroenterol Hepatol (2013) 0.75
Rheumatoid arthritis: Add-on treatment after methotrexate failure in early RA--the debate continues. Nat Rev Rheumatol (2012) 0.75
NASH: KLF6 activates PPARα signalling in hepatic steatosis. Nat Rev Gastroenterol Hepatol (2013) 0.75
Bone: An alternative pathway for bone destruction in inflammatory arthritis? Nat Rev Rheumatol (2012) 0.75
Chest radiography not needed in seminoma surveillance. Nat Rev Urol (2010) 0.75
Motility: Searching for 5-HT4 receptors in the colonic mucosa. Nat Rev Gastroenterol Hepatol (2012) 0.75
Stroke: fluoxetine improves motor function after acute ischemic stroke. Nat Rev Neurol (2011) 0.75
Biomarkers: New prognostic biomarker for autoimmune diseases. Nat Rev Rheumatol (2010) 0.75
IBD: the IBD genome--new study findings contribute to an ever-growing gene catalogue. Nat Rev Gastroenterol Hepatol (2012) 0.75
Connective tissue diseases: VSMC contraction in Systemic sclerosis. Nat Rev Rheumatol (2011) 0.75
Bone: Cdc42 has a key role in modulating osteoclast formation and function. Nat Rev Rheumatol (2010) 0.75
Infection: Lactobacillus probiotic could prevent recurrent UTI. Nat Rev Urol (2011) 0.75
Pancreatic cancer: Radioactive Listeria delivers killer hit to metastatic pancreatic cancer. Nat Rev Gastroenterol Hepatol (2013) 0.75
Hepatitis: Cryoblobulinemia—a useful predictor of treatment response in patients with chronic HCV infection? Nat Rev Gastroenterol Hepatol (2011) 0.75
Neurodegenerative disease: Mitochondria, huntingtin and HD. Nat Rev Neurol (2011) 0.75
Genetics: ADRB2 polymorphism predicts FGID diagnoses and quality of life. Nat Rev Gastroenterol Hepatol (2013) 0.75
Epilepsy: antiepileptic drugs reduce vitamin B(12) and folate levels. Nat Rev Neurol (2011) 0.75
CPB2 dampens inflammation in autoimmune arthritis. Nat Rev Rheumatol (2011) 0.75
Pancreas: Microglial activation key to pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol (2011) 0.75
Liver: Fgf15 maintains bile acid homeostasis and is a key mediator of liver regeneration in mice. Nat Rev Gastroenterol Hepatol (2013) 0.75
IBD: Intestinal inflammation affected by density of enteric neurons. Nat Rev Gastroenterol Hepatol (2011) 0.75
Movement disorders: Cerebellum and basal ganglia interaction essential in RDP. Nat Rev Neurol (2011) 0.75
Stem cells: Boosted bone healing in the MSC matrix. Nat Rev Rheumatol (2012) 0.75
Bladder cancer: Neoadjuvant MVAC chemotherapy best for 'mixed' tumors? Nat Rev Urol (2011) 0.75
Doxercalciferol is as effective as calcitriol for the treatment of secondary hyperparathyroidism in CKD. Nat Rev Nephrol (2010) 0.75
Pain: Statins--new treatment for neuropathic pain? Nat Rev Neurol (2011) 0.75
Pediatrics: Repeated botulinum toxin-A injections safe in children. Nat Rev Urol (2011) 0.75
Rapid fluid removal and cardiovascular mortality. Nat Rev Nephrol (2011) 0.75
Surgery: tumor risk after urinary diversion. Nat Rev Urol (2011) 0.75
Clostridium difficile: Restoring the balance--microbes for the management of Clostridium difficile infection? Nat Rev Gastroenterol Hepatol (2013) 0.75
Obesity: Unsaturated fatty acids aggravate acute pancreatitis. Nat Rev Gastroenterol Hepatol (2011) 0.75
Transplantation: Host stem cells boost tolerance of liver grafts. Nat Rev Gastroenterol Hepatol (2011) 0.75
Colorectal cancer: A single-cell snapshot of gene expression in healthy and cancerous colon tissue. Nat Rev Gastroenterol Hepatol (2011) 0.75
Interventional cardiology: TAVI--better than SAVR in high-risk patients? Nat Rev Cardiol (2011) 0.75
Connective tissue diseases: Immune responses in Mikulicz disease differ from those in SS. Nat Rev Rheumatol (2011) 0.75